The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Mengler Christopher since 2006.
The trader's CIK number is 1336015.
At the time of the last reporting, Mengler Christopher was the President, Global Ph of Impax Laboratories Inc. (stock ticker symbol IPXL).
Also see all insider trading activities at Impax Laboratories Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2007 | BRL | 0 | $0 | 3,022 | $152,058 | 3,022 | $109,808 |
| 2006 | BRL | 0 | $0 | 3,000 | $184,896 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2010 | IPXL | 2,000 | $30,380 | 50,416 | $1,056,552 | 0 | $0 |
| 2009 | IPXL | 17,000 | $98,850 | 0 | $0 | 0 | $0 |
1. Barr Pharmaceuticals Inc (BRL)
2. Impax Laboratories Inc (IPXL)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-03-07 | BRL | Sale | 22 | 49.13 | 1,080 |
| 2007-03-06 | BRL | Option Ex | 22 | 48.54 | 1,067 |
| 2007-01-03 | BRL | Option Ex | 3,000 | 36.25 | 108,741 |
| 2007-01-03 | BRL | Sale | 3,000 | 50.33 | 150,978 |
| 2006-01-03 | BRL | Sale | 3,000 | 61.63 | 184,896 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2010-11-05 | IPXL | Sale | 7,460 | 19.32 | 144,127 |
| 2010-10-25 | IPXL | Sale | 40,956 | 21.24 | 869,905 |
| 2010-10-22 | IPXL | Sale | 2,000 | 21.26 | 42,520 |
| 2010-08-12 | IPXL | Buy | 2,000 | 15.19 | 30,380 |
| 2009-05-08 | IPXL | Buy | 1,000 | 5.85 | 5,850 |
| 2009-03-25 | IPXL | Buy | 1,000 | 5.50 | 5,500 |
| 2009-03-12 | IPXL.OB | Buy | 5,000 | 5.50 | 27,500 |
| 2009-03-03 | IPXL.OB | Buy | 10,000 | 6.00 | 60,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mengler Christopher (President, Global Ph of Impax Laboratories Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.